7. A pharmacy technician compounds a tretinoin oral suspension and finds that the drug pamphlet does not provide instruction for assigning a beyond-use date. The technician should refer to beyond-use dating guidelines found in USP Chapter:
Answer: B
The technician should refer to beyond-use dating guidelines found in USP Chapter 795.
USP Chapter 795 provides guidelines for the compounding of non-sterile preparations, including the assignment of beyond-use dates. This chapter outlines the appropriate practices and considerations that must be taken into account when determining how long a compounded preparation remains safe and effective for patient use.
A) 37
USP Chapter 37 does not exist in the context of compounding guidelines. Therefore, it cannot provide relevant information regarding beyond-use dating for compounded medications.
B) 795
USP Chapter 795 specifically addresses the compounding of non-sterile preparations and includes detailed guidance on assigning beyond-use dates. This makes it the correct reference for the pharmacy technician in this scenario.
C) 797
USP Chapter 797 deals with the compounding of sterile preparations, focusing on practices that ensure the safety and quality of injectable and other sterile products. While important, it does not pertain to beyond-use dating for non-sterile formulations.
D) 800
USP Chapter 800 provides guidelines related to the handling of hazardous drugs in healthcare settings. Although it is vital for safety practices, it does not address beyond-use dating for compounded preparations.
Conclusion
The technician should rely on USP Chapter 795 for guidance on beyond-use dating for the compounded tretinoin oral suspension, as it specifically covers non-sterile compounding practices. The other options (37, 797, and 800) do not provide relevant information regarding the assignment of beyond-use dates, making them incorrect choices in this context.